Friday, October 9, 2015: 12:30 PM-2:00 PM
Room: Poster Hall
Learning Objectives:
-
Tracks: Adult ID, Pediatric ID, Epidemiology and Infection Control
Presentations:
Risk Factors for Community-Associated Clostridium Difficile Infection: a Case Control Study
Susan N. Hocevar, MD
;
Sandra N. Bulens, MPH
;
Monica Farley, MD, FIDSA
;
Stacy Holzbauer, DVM, MPH, DACVPM
;
Emily B. Hancock, MS
;
Ghinwa Dumyati, MD, FSHEA
;
Corinne M. Davis, MPH
;
Carol Lyons, MPH
;
Rebecca Perlmutter, MPH
;
Erin Parker, MPH
;
Claire Reisenauer, DVM
;
Valerie L.S. Ocampo, RN, MIPH
;
Yi Mu, PhD
;
L. Clifford Mcdonald, MD, FSHEA
Independent Risk Factors for Recurrence of Clostridium difficile Infection: A Canadian Multicenter Prospective Cohort
Claire Nour Abou Chakra, MSc
;
Allison Mcgeer, MD, MSc, FRCPC, FSHEA
;
Annie-Claude Labbé, MD, FRCPC
;
Andrew E. Simor, MD, FRCPC, FACP, FIDSA, FSHEA
;
Wayne Gold, MD
;
Matthew P. Muller, MD, PhD, FRCPC
;
Jeff Powis, MD, MSc, FRCPC
;
Kevin Katz, MD, CM, MSc, FRCPC
;
Julian R. Garneau, BSc
;
Louis-Charles Fortier, PhD
;
Jacques Pepin, MD, MSc
;
Louis Valiquette, MD, MSc
Molecular and Clinical Epidemiology of Clostridium difficile Infection (CDI) in Three Diverse Medical Centers in New York
Marisa Montecalvo, MD
;
Mini Kamboj, MD
;
Donna Mckenna, ANP MS
;
Jonathan Menz, MBA
;
Liz Klimczak, RN MS
;
Melody Zolendjeski, RN
;
Guiqing Wang, MD, PhD
;
Gary Wormser, MD, FIDSA
Geographic Distribution of Clostridium difficile Infection Burden by Various Counties in Michigan
Babbaljeet Kaur, MD
;
Paul Kilgore, MD, MPH
;
Abdulbaset Salim, MD, MPH
;
Elizabeth Waldman, MPH
;
Gloria E. Pizzo, RN/BSN
;
Harolyn Baker, MPH
;
Jackie Rosenblatt, PhD
;
Keith Kaye, MD, MPH, FIDSA, FSHEA
;
Teena Chopra, MD, MPH
Candida Co-infection among Adults with Clostridium difficile Infection in Metropolitan Atlanta, 2009„Ÿ2013
Snigdha Vallabhaneni, MD, MPH
;
Olivia M. Almendares, MSPH
;
Monica Farley, MD, FIDSA
;
Jessica Reno, MPH
;
Zirka Smith, MPH
;
Betsy Stein, RN, BSN
;
Shelley S. Magill, MD, PhD
;
Rachel M. Smith, MD, MPH
;
Angela Cleveland, MPH
;
Fernanda C. Lessa, MD
Consensus Definition of Clostridium Difficile Infections That Are Not Preventable by Antibiotic Stewardship Programs
Jessica Seidelman, M.D.
;
Kristen V. Dicks, MD
;
Sarah S. Lewis, MD MPH
;
Michael J. Durkin, MD, MPH
;
Arthur W. Baker, MD, MPH
;
Rebekah W. Moehring, MD, MPH
;
Deverick Anderson, MD, MPH, FIDSA, FSHEA
;
Daniel J. Sexton, MD, FIDSA, FSHEA
;
Luke F. Chen, MBBS, MPH, CIC, FRACP
Harnessing granular data from comprehensive electronic medical records for prediction of recurrent Clostridium difficile infection – challenges and opportunities
Gabriel Escobar, MD
;
Jennifer Baker, B.S.
;
John Greene, M.A.
;
Juan Carlos Laguardia, M.S.
;
Nicole Cossrow, MPH, PhD
;
Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA
Risk Factors for Clostridium difficile Infection Recurrence
Sujan C. Reddy, MD
;
Alice Guh, MD, MPH
;
Fernanda C. Lessa, MD
;
Yi Mu, PhD
;
Zintars G. Beldavs, MS
;
Corinne M. Davis, MPH
;
Ghinwa Dumyati, MD, FSHEA
;
Stacy M. Holzbauer, DVM, MPH
;
Helen L. Johnston, MPH
;
Carol Lyons, MPH
;
Erin C. Phipps, DVM, MPH
;
Lucy E. Wilson, MD
;
Lisa G. Winston, MD
;
Dale N. Gerding, MD, FIDSA
;
L. Clifford Mcdonald, MD, FSHEA
;
Monica Farley, MD, FIDSA
Serum Inflammatory Mediator Profiles Differentiate Patients with Complicated and Uncomplicated Clostridium difficile Infection
Krishna Rao, MD, MS
;
Kavitha Santhosh, MD
;
Jill Mogle, LPN
;
Andrezj T. Galecki, MD, PhD
;
Peter D. R. Higgins, MD, PhD
;
Vincent B. Young, MD, PhD, FIDSA
Fecal Biomarkers of Clostridium Difficile (CD) Associated Disease (CDAD)
Xunyan Ye, PhD
;
Meina Zhao, PhD
;
Alejandro Restrepo, M.D.
;
John Van, BA
;
Todd M. Lasco, PhD
;
Kevin W. Garey, PharmD, M.S.
;
Herbert Dupont, MD, FIDSA
;
Hoonmo L. Koo, MD, MPH
The Food of Hospitalized Patients as a Risk Factor for Acquisition of Clostridium difficile: A Modeling Study
Jennie H. Kwon, D.O.
;
Cristina Lanzas, DVM, PhD
;
Kimberly Reske, MPH
;
Tiffany Hink, BS
;
Sondra Seiler, BA
;
Carey-Ann D. Burnham, PhD
;
Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA
Characteristics of fecal microbiota in Korean patients with Clostridium difficile associated diarrhea
Hea Won Ann, MD
;
Jin Young Ahn, MD
;
Young Soun Lim, M.S
;
Mi-Young Ahn, MD
;
Yong Duk Jeon, MD
;
In Young Jung, MD
;
Nam Su Ku, MD
;
Dongeun Yong, MD, PhD
;
Kyungwon Lee, MD, PhD
;
June Myung Kim, MD, PhD
;
Jun Yong Choi, MD, PhD
Evaluation of the performance of the Target Enriched Multiplex Polymerase Chain Reaction (TEM-PCR) Gastrointestinal (GI) Panel vs the Cepheid Xpert C. difficile/Epi assay for the detection of toxigenic Clostridium difficile
Khushdeep Chahal, MD
;
Esmeralda Gutierrez-Asis, MD
;
Farrah Ibrahim, MD FACP
;
Elena Grigorenko, PhD
;
Stefan Brzezinski, MBA, BS
;
Donald Stalons, PhD, D(ABMM), MPH
;
Ali Hassoun, MD FIDSA FACP
Detection of Clostridium difficile by Real-Time Polymerase Chain Reaction in Young Children Does Not Predict Diarrhea
Barbara Pahud, MD MPH
;
Christopher Harrison, M.D., FSHEA, FPIDS
;
Ferdaus Hassan, PhD
;
Natasha Halasa, MD, MPH, FPIDS
;
James D. Chappell, MD, PhD
;
Janet Englund, MD, FIDSA
;
Eileen Klein, MD, MPH
;
Peter G Szilagyi, MD, MPH
;
Geoffrey Weinberg, MD, FIDSA, FPIDS
;
Christopher Polage, MD
;
Mary E. Wikswo, MPH
;
L. Clifford Mcdonald, MD, FSHEA
;
Daniel Payne, PhD, MSPH
;
Rangaraj Selvarangan, PhD
In Vivo Correlation Between Clostridium difficile Toxin and Spore levels in Symptomatic CDI Patients
Natalia Blanco, MPH
;
Anurag Malani, MD, FIDSA
;
Marisa Eisenberg, PhD, MS
;
Alexander Rickard, PhD, MSc, BSc
;
Seth Walk, PhD
;
Betsy Foxman, PhD, FIDSA
CME Credits:
ACPE Credits:
ACPE Number: